May 22, 2025

At-Home HPV Test Matches Clinic Accuracy

Researchers found that an at-home self-collection device for HPV testing demonstrated high accuracy and safety, matching clinician-collected results for cervical cancer screening.

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 21, 2025

Diabetes Drug TZDs May Curb Prostate Cancer

Older type 2 diabetes drugs that target PPAR-gamma may slow prostate cancer progression.

Reuters

May 21, 2025

New Biomarkers for Ultraprocessed Food Intake

NCI researchers identified blood and urine metabolite patterns that objectively measure ultraprocessed food consumption.

Conexiant

May 20, 2025

Breast Texture Patterns May Detect Missed Cancer

Researchers analyzed over 30,000 mammograms and found that specific breast texture patterns can predict cancer risk and missed diagnoses—even beyond breast density.

Conexiant

May 19, 2025

Protein-Based COVID Vaccine Gains FDA Approval

The FDA has approved the first recombinant protein-based, non-mRNA COVID-19 vaccine.

Conexiant

May 16, 2025

FDA Approves PD-1–Targeted Monoclonal Antibody for SCAC

The FDA has approved Zynyz (retifanlimab-dlwr) as the first programmed death receptor-1 inhibitor for first-line treatment of advanced squamous cell carcinoma of the anal canal.

Conexiant

May 16, 2025

Long-Term Data Support BCT for BRCA-Mutated Breast Cancer

Researchers found that breast-conserving treatment provided long-term survival outcomes comparable to mastectomy in patients with breast cancer and BRCA1 or BRCA2 pathogenic variants.

Conexiant

May 16, 2025

Delandistrogene Moxeparvovec: Efficacy Evidence Questioned

The AAN Guidelines Subcommittee review finds delandistrogene moxeparvovec for DMD failed to meet primary functional outcomes despite FDA approval.

Conexiant